303 related articles for article (PubMed ID: 35037033)
1. Implementation and Short-term Adverse Events of Anti-SARS-CoV-2 Vaccines in Inflammatory Bowel Disease Patients: An International Web-based Survey.
Ellul P; Revés J; Abreu B; Chaparro M; Gisbert JP; Allocca M; Fiorino G; Barberio B; Zingone F; Pisani A; Cassar D; Michalopoulos G; Mantzaris G; Koutroubakis I; Karmiris K; Katsanos K; Ďuricova D; Burisch J; Madsen GR; Maaser C; Naila A; Orfanoudaki E; Milivojevic V; Buisson A; Avedano L; Leone S; Torres J
J Crohns Colitis; 2022 Aug; 16(7):1070-1078. PubMed ID: 35037033
[TBL] [Abstract][Full Text] [Related]
2. Impact of SARS-CoV-2 Vaccination on Inflammatory Bowel Disease Activity and Development of Vaccine-Related Adverse Events: Results From PREVENT-COVID.
Weaver KN; Zhang X; Dai X; Watkins R; Adler J; Dubinsky MC; Kastl A; Bousvaros A; Strople JA; Cross RK; Higgins PDR; Ungaro RC; Bewtra M; Bellaguarda E; Farraye FA; Boccieri ME; Firestine A; Kappelman MD; Long MD
Inflamm Bowel Dis; 2022 Oct; 28(10):1497-1505. PubMed ID: 34871388
[TBL] [Abstract][Full Text] [Related]
3. SARS-CoV-2 vaccination in patients with inflammatory bowel disease: A systemic review and meta-analysis.
Sung KY; Chang TE; Wang YP; Lin CC; Chang CY; Hou MC; Lu CL
J Chin Med Assoc; 2022 Apr; 85(4):421-430. PubMed ID: 34974509
[TBL] [Abstract][Full Text] [Related]
4. Safety of SARS-CoV-2 vaccination in patients with inflammatory bowel disease: A systematic review and meta-analysis.
James D; Jena A; Bharath PN; Choudhury A; Singh AK; Sebastian S; Sharma V
Dig Liver Dis; 2022 Jun; 54(6):713-721. PubMed ID: 35382972
[TBL] [Abstract][Full Text] [Related]
5. Patients With Inflammatory Bowel Diseases Have Impaired Antibody Production After Anti-SARS-CoV-2 Vaccination: Results From a Panhellenic Registry.
Zacharopoulou E; Orfanoudaki E; Tzouvala M; Tribonias G; Kokkotis G; Kitsou V; Almpani F; Christidou A; Viazis N; Mantzaris GJ; Tsafaridou M; Karmiris K; Theodoropoulou A; Papathanasiou E; Zampeli E; Michopoulos S; Tigkas S; Michalopoulos G; Laoudi E; Karatzas P; Mylonas I; Kyriakos N; Liatsos C; Kafetzi T; Theocharis G; Taka S; Panagiotopoulou K; Koutroubakis IE; Bamias G
Inflamm Bowel Dis; 2023 Feb; 29(2):228-237. PubMed ID: 35394529
[TBL] [Abstract][Full Text] [Related]
6. Safety, hesitancy of coronavirus disease 2019 vaccination and pandemic burden in patients with inflammatory bowel disease: data of a national study (ESCAPE-IBD).
Principi M; Macaluso FS; Todeschini A; Facciotti F; Contaldo A; Castiglione F; Nardone OM; Spagnuolo R; Doldo P; Riguccio G; Conforti FS; Viganò C; Ascolani M; Fiorino G; Correale C; Bodini G; Milla M; Scardino G; Vernero M; Desideri F; Caprioli F; Mannino M; Rizzo G; Orlando A;
Eur J Gastroenterol Hepatol; 2023 Jun; 35(6):629-634. PubMed ID: 37115976
[TBL] [Abstract][Full Text] [Related]
7. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
Akova M; Unal S
Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness and safety of SARS-CoV-2 vaccine in Inflammatory Bowel Disease patients: a systematic review, meta-analysis and meta-regression.
Bhurwal A; Mutneja H; Bansal V; Goel A; Arora S; Attar B; Minacapelli CD; Kochhar G; Chen LA; Brant S; Seril D
Aliment Pharmacol Ther; 2022 May; 55(10):1244-1264. PubMed ID: 35355306
[TBL] [Abstract][Full Text] [Related]
9. COVID-19 vaccination rate and willingness of an additional dose among inflammatory bowel disease patients receiving biologic therapy: Fearless and with desire.
Ramos L; Carrillo-Palau M; Alonso-Abreu I; Reygosa C; Hernández-Alvarez N; Amaral C; Hernández A; Benítez-Zafra F; Pérez-González F; Quintana-Díaz H; Hernandez-Guerra M
Gastroenterol Hepatol; 2023 Apr; 46(4):255-260. PubMed ID: 35609791
[TBL] [Abstract][Full Text] [Related]
10. SARS-CoV-2 vaccination for patients with inflammatory bowel disease: a British Society of Gastroenterology Inflammatory Bowel Disease section and IBD Clinical Research Group position statement.
Alexander JL; Moran GW; Gaya DR; Raine T; Hart A; Kennedy NA; Lindsay JO; MacDonald J; Segal JP; Sebastian S; Selinger CP; Parkes M; Smith PJ; Dhar A; Subramanian S; Arasaradnam R; Lamb CA; Ahmad T; Lees CW; Dobson L; Wakeman R; Iqbal TH; Arnott I; Powell N;
Lancet Gastroenterol Hepatol; 2021 Mar; 6(3):218-224. PubMed ID: 33508241
[TBL] [Abstract][Full Text] [Related]
11. Adverse Events and Serological Responses After SARS-CoV-2 Vaccination in Individuals With Inflammatory Bowel Disease.
Markovinović A; Quan J; Herauf M; Hracs L; Windsor JW; Sharifi N; Coward S; Caplan L; Gorospe J; Ernest-Suarez K; Ma C; Panaccione R; Ingram RJM; Kanji JN; Tipples G; Holodinsky JK; Bernstein CN; Mahoney DJ; Bernatsky S; Benchimol EI; Kaplan GG; ;
Am J Gastroenterol; 2023 Sep; 118(9):1693-1697. PubMed ID: 37216598
[TBL] [Abstract][Full Text] [Related]
12. SARS-CoV-2 vaccination does not induce relapses of patients with inflammatory bowel disease.
Elkharsawi A; Arnim UV; Schmelz R; Sander C; Stallmach A; Teich N; Walldorf J; Reuken PA
Z Gastroenterol; 2022 Jan; 60(1):77-80. PubMed ID: 35042256
[TBL] [Abstract][Full Text] [Related]
13. Antibody Response to SARS-CoV-2 Vaccination in Patients with Inflammatory Bowel Disease: Results of a Single-Center Cohort Study in a Tertiary Hospital in Germany.
Classen JM; Muzalyova A; Nagl S; Fleischmann C; Ebigbo A; Römmele C; Messmann H; Schnoy E
Dig Dis; 2022; 40(6):719-727. PubMed ID: 34915480
[TBL] [Abstract][Full Text] [Related]
14. Misconceptions Drive COVID-19 Vaccine Hesistancy in Individuals with Inflammatory Bowel Disease.
Zhang E; Gupta A; Al-Ani A; Macrae FA; Leong RW; Christensen B
Can J Gastroenterol Hepatol; 2022; 2022():4527844. PubMed ID: 36124090
[TBL] [Abstract][Full Text] [Related]
15. Postvaccination Symptoms After a Third Dose of mRNA SARS-CoV-2 Vaccination in Patients With Inflammatory Bowel Disease: Results From CORALE-IBD.
Li D; Debbas P; Mujukian A; Cheng S; Braun J; McGovern DPB; Melmed GY;
Inflamm Bowel Dis; 2023 Jun; 29(6):883-887. PubMed ID: 35998072
[TBL] [Abstract][Full Text] [Related]
16. Humoral Immune Response and Safety of SARS-CoV-2 Vaccination in Pediatric Inflammatory Bowel Disease.
Kastl AJ; Weaver KN; Zhang X; Strople JA; Adler J; Dubinsky MC; Bousvaros A; Watkins R; Dai X; Chen W; Cross RK; Higgins PDR; Ungaro RC; Bewtra M; Bellaguarda EA; Farraye FA; Chun KY; Zikry M; Fernando M; Bastidas M; Hernandez CG; Craig RG; Boccieri ME; Firestine A; Long MD; Kappelman MD
Am J Gastroenterol; 2023 Jan; 118(1):129-137. PubMed ID: 36114773
[TBL] [Abstract][Full Text] [Related]
17. SARS-CoV-2 vaccination in inflammatory bowel disease patients is not associated with flares: a retrospective single-centre Swiss study.
Rossier LN; Décosterd NP; Matter CB; Staudenmann DA; Moser A; Egger B; Seibold FW
Ann Med; 2024 Dec; 56(1):2295979. PubMed ID: 38289017
[TBL] [Abstract][Full Text] [Related]
18. COVID-19 vaccination safety and associated health care utilization among adults with inflammatory bowel disease - a population-based self-controlled case series analysis.
Lee JJY; Bernatsky S; Benchimol EI; Kuenzig ME; Kwong JC; Li Q; Widdifield J
BMC Gastroenterol; 2024 May; 24(1):189. PubMed ID: 38816836
[TBL] [Abstract][Full Text] [Related]
19. Recent advances in clinical practice: management of inflammatory bowel disease during the COVID-19 pandemic.
Lin S; Lau LH; Chanchlani N; Kennedy NA; Ng SC
Gut; 2022 Jul; 71(7):1426-1439. PubMed ID: 35477864
[TBL] [Abstract][Full Text] [Related]
20. COVID-19 vaccination in patients with primary immunodeficiencies: an international survey on patient vaccine hesitancy and self-reported adverse events.
Pergent M; Haerynck F; Hoste L; Gardulf A
Front Immunol; 2023; 14():1166198. PubMed ID: 37143673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
